Astera Labs CEO Mohan Jitendra sells shares worth $31.4 million

Published 21/02/2025, 23:40
Astera Labs CEO Mohan Jitendra sells shares worth $31.4 million

SANTA CLARA, CA—Astera Labs, Inc. (NASDAQ:ALAB), a semiconductor company with a market capitalization of $14.25 billion, Chief Executive Officer Mohan Jitendra has sold shares of the company’s common stock amounting to approximately $31.4 million, according to a recent regulatory filing. The transactions took place on February 19, 2025, and involved a series of sales at prices ranging from $87.83 to $92.35 per share, near the current trading price of $85.72.

The sales were executed to satisfy tax withholding obligations related to the vesting and settlement of restricted stock units previously granted to Jitendra. Following these transactions, Jitendra retains direct ownership of 2,353,655 shares of Astera Labs .

In addition to his direct holdings, Jitendra has indirect ownership through various trusts, including a living trust and estate planning trusts, totaling several million shares. The transactions were part of a pre-planned arrangement to cover tax liabilities and do not represent discretionary trades by the CEO.

Astera Labs, based in Santa Clara, California, is a prominent player in the semiconductor industry, focusing on developing connectivity solutions for data-centric systems.

In other recent news, Astera Labs reported strong financial results for the fourth quarter of 2024, achieving a record revenue of $141.1 million, which marks a 179% increase year-over-year. The company also provided guidance for the first quarter of 2025, expecting revenues between $151 million and $155 million, indicating continued growth. Stifel analysts maintained a Buy rating on Astera Labs with a $150 price target, noting the company’s exceptional year-over-year revenue growth of 242.2% and highlighting the company’s potential in the Scorpio PCIe switch solutions market. Needham also reiterated a Buy rating with a $140 price target, emphasizing the robust sales of Astera Labs’ Taurus and Aries product lines and the anticipated revenue contributions from the Scorpio product family. Jefferies maintained its Buy rating with an $85 price target, despite a pullback in stock price, and expressed optimism about the company’s earnings per share potential and growth opportunities with partners like Nvidia (NASDAQ:NVDA) and Amazon (NASDAQ:AMZN). These developments reflect analysts’ confidence in Astera Labs’ growth trajectory and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.